1. COVID-19 cytokine storm: The anger of inflammation.
- Author
-
Mahmudpour, Mehdi, Roozbeh, Jamshid, Keshavarz, Mohsen, Farrokhi, Shokrollah, and Nabipour, Iraj
- Subjects
- *
CYTOKINE release syndrome , *COVID-19 , *COMPLEMENT receptors , *ADULT respiratory distress syndrome , *RENIN-angiotensin system , *ANGIOTENSIN converting enzyme - Abstract
• Increased activity of the RAAS system occurs in the COVID-19 induced cytokine storm. • The COVID-19 induced cytokine storm is accompanied with attenuation of MasR activity. • The SARS-CoV-2 associated ACE2 induces DABK and BKB1R hyper-activation. • The COVID-19 induced cytokine storm leads to hyperactivity of the complement system. Patients with COVID-19 who require ICU admission might have the cytokine storm. It is a state of out-of-control release of a variety of inflammatory cytokines. The molecular mechanism of the cytokine storm has not been explored extensively yet. The attachment of SARS-CoV-2 spike glycoprotein with angiotensin-converting enzyme 2 (ACE2), as its cellular receptor, triggers complex molecular events that leads to hyperinflammation. Four molecular axes that may be involved in SARS-CoV-2 driven inflammatory cytokine overproduction are addressed in this work. The virus-mediated down-regulation of ACE2 causes a burst of inflammatory cytokine release through dysregulation of the renin-angiotensin-aldosterone system (ACE/angiotensin II/AT1R axis), attenuation of Mas receptor (ACE2/MasR axis), increased activation of [des-Arg9]-bradykinin (ACE2/bradykinin B1R/DABK axis), and activation of the complement system including C5a and C5b-9 components. The molecular clarification of these axes will elucidate an array of therapeutic strategies to confront the cytokine storm in order to prevent and treat COVID-19 associated acute respiratory distress syndrome. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF